The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both?  Jeffrey Perl, Sharon J. Nessim, Joanne M. Bargman  Kidney International  Volume 79, Issue 8, Pages 814-824 (April 2011) DOI: 10.1038/ki.2010.515 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 The GDP content among commercially available neutral pH, low-GDP peritoneal dialysis solutions (solutions 1–4) compared with the GDP content of conventional peritoneal dialysis solutions (solution 5). 3-DG, 3-deoxyglucosone; 3,4-DGE, 3,4-dideoxyglucosone-3-ene; 5-HMF, 5-hydroxymethyl furaldehyde; AcA, acetaldehyde; FoA, formaldehyde; GDP, glucose degradation product. *GDP concentrations for conventional peritoneal dialysis solutions (solution 5) were taken as an average from published values for Gambrosol, StaySafe, and Dianeal. All solutions are prepared using a commercially available 2.5% glucose concentration peritoneal dialysis solution. Total GDP content as measured by the summation of the individual glucose degradation products measured. Adapted from Erixon M. et al.10 Kidney International 2011 79, 814-824DOI: (10.1038/ki.2010.515) Copyright © 2011 International Society of Nephrology Terms and Conditions